The government agency says X no longer suits its communication needs.

The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming ...

Submission supported by positive results from global, Phase 3 4WHIM clinical trial;U.S. regulatory approval in WHIM syndrome granted in ...

X4 Pharmaceuticals (XFOR) announced that its Marketing Authorization Application for mavorixafor for the treatment of WHIM syndrome, a rare ...

Applications are based on data from the DEVOTE study, which demonstrate the potential for the investigational higher dose regimen of nusinersen to advance the treatment of SMA CAMBRIDGE, Mass., Jan. 2 ...

Patients and doctors. Health experts and, above all, patients will have a new framework that will help address unmet medical ...

The European Committee of Social Rights (ECSR) will hold its 346th plenary session in Strasbourg from 20 to 23 January 2025. This first plenary session of 2025 will focus notably on the adoption of ...

Some medicines need to be given at a certain time to make sure they are safe or work effectively. The stomach or intestinal contents can affect the absorption of some medicines. Some medicines need to ...

The EES scheme is different to the European Travel Information and Authorisation Scheme (ETIAS), which will run alongside the former and require British travellers to apply for a visa waiver to ...

The purpose of this evaluation report is to provide Canadians, the Commissioner, Canada Revenue Agency (CRA) management, and the Board of Management with an assessment of the outcomes achieved and the ...